The role of interatrial stenting in the management of CHD

Mehmet Balci1, Sezen Ugan Atik1, Selman Gokalp1

  • 1Pediatric Cardiology, Ministry of Health Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training Hospital, Türkiye.

Insights

Interatrial stenting is a safe and effective treatment for pediatric congenital heart disease (CHD), improving hemodynamics. This study evaluated its success and outcomes in young patients.

Area of Science:

  • Pediatric Cardiology
  • Interventional Cardiology
  • Congenital Heart Disease

Background:

  • Interatrial stenting is crucial for optimizing hemodynamics in pediatric congenital heart disease (CHD).
  • It establishes sustained interatrial communication.
  • This intervention is vital for managing complex cardiac conditions in children.

Purpose of the Study:

  • To evaluate the procedural success of interatrial stenting in pediatric patients.
  • To assess clinical outcomes and mortality rates post-intervention.
  • To identify factors influencing hemodynamic improvement after stenting.

Main Methods:

  • A retrospective analysis of 16 pediatric patients undergoing interatrial stenting (2018-2024).
  • Patients were grouped by age: ≤12 months (Group 1) and >12 months (Group 2).
  • Demographic, procedural, and follow-up data were analyzed.

Main Results:

  • Procedural success was high (93.8%), with one acute failure.
  • Common diagnoses included borderline left ventricle and hypoplastic left heart syndrome.
  • Median follow-up was 17.5 months; 37.5% mortality, no stent thrombosis.

Conclusions:

  • Interatrial stenting is a safe and effective palliative option for pediatric CHD.
  • It significantly improves hemodynamics.
  • The procedure serves as a bridge to definitive surgical treatment.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
465
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
495
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.3K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
641
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
718
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
377